The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
MK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAMEBDB
Gilead Sciences
ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTORBDB
Diamond Therapeutics Inc.
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORSBDB
Theravance Biopharma R&D Ip
Anti-cancer nuclear hormone receptor-targeting compoundsBDB
Nuvation Bio
2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using sameBDB
The Trustees of The University of Pennsylvania
Class of amino-substituted nitrogen-containing fused ring compounds, preparation method therefor, and use thereofBDB
Shanghai Ringene Biopharma
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsBDB
Ideaya Biosciences
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesBDB
Array Biopharma
Composition for suppressing neuraminidase activity comprising geranylated flavonoid derived from Paulownia tomentosa as active ingredientBDB
Industry-Academic Cooperation Foundation Gyeongsang National University
Substituted imidazopyridazinesBDB
Bayer Intellectual Property
Antagonists of prostaglandin EP3 receptorBDB
Pfizer
Inhibitors of beta-secretaseBDB
Vitae Pharmaceuticals
Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disordersBDB
Janssen Pharmaceutica
Substituted imidazo[1,2-a]pyrimidines and —pyridinesBDB
Bayer Intellectual Property
(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activityBDB
Novartis
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))BDB
Galderma Research & Development